Evidence map›Paper›PMID 42002529›Full record

ArticleThe Medical journal of Australia2026

The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention.

Cyra Patel, Alexis Pillsbury, Tran Nguyen, Xia Wang, Helen E Quinn, Clayton K Chiu, Allen C Cheng, Katie L Flanagan, Zhicheng Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Medical journal of Australia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cyra PatelUniversity of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-3529-0445
Alexis PillsburyUniversity of Sydney, Sydney, New South Wales, Australia.
Tran NguyenNational Centre for Immunisation Research and Surveillance, Sydney, New South Wales, Australia.
Xia WangUniversity of Sydney, Sydney, New South Wales, Australia.
Helen E QuinnUniversity of Sydney, Sydney, New South Wales, Australia.
Clayton K ChiuUniversity of Sydney, Sydney, New South Wales, Australia.
Allen C ChengMonash University, Melbourne, Victoria, Australia.ORCID 0000-0003-3152-116X
Katie L FlanaganCentre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.
Zhicheng WangUniversity of Sydney, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seasonal influenza causes significant morbidity and mortality in Australia. Despite long-standing recommendations for influenza vaccination and nationally funded programs for higher risk age or population groups, coverage remains suboptimal, especially among children. Introduction of the intranasal live attenuated influenza vaccine (LAIV) in 2026 offers an additional safe and effective needle-free vaccine option. Easier administration may improve access by making delivery by a range of health care providers possible. This perspective article outlines the evidence supporting the use of the LAIV and its potential to improve vaccination uptake among children in Australia.

Indexed as

Influenza, HumanInfluenza VaccinesAdministration, IntranasalAustraliaChildHumansVaccinationVaccines, AttenuatedInfluenza VaccinesVaccines, Attenuatedchildhood diseaseschildhood vaccinationinfectious diseasesvaccination coverage

Identifiers

PMID42002529
PMCPMC13092460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.